Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 3,601–3,620 of 18,346 recalls

FDA Recall Ongoing Historical recordClass I

Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.) tube, Distributed By: Delsam Pharma Lic, Bronx, Newyork 10469, NDC 72570 122 35, UPC 3 72570 12235 3.

by Global Pharma Healthcare Private Limited

Reason
Non-Sterility: FDA analysis found unopened tubes to be contaminated with bacteria.
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Content Uniformity Specifications
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3

by Noven Pharmaceuticals Inc

Reason
Defective Delivery System: Out of specification for shear.
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3.

by Noven Pharmaceuticals Inc

Reason
Defective Delivery System: Out of specification for shear.
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

by Noven Pharmaceuticals Inc

Reason
Defective Delivery System: Out of specification for shear.
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

by Noven Pharmaceuticals Inc

Reason
Defective Delivery System: Out of specification for shear.
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Eli Lilly and Company Indianapolis, IN 46285 USA

by Boehringer Ingelheim Pharmaceuticals, Inc.

Reason
Labeling: Label Mix-up
Published
March 29, 2023
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Dollar General Corporation

Product
DG Health brand Sugar Free Daily Fiber in 10 oz. plastic con…
Reason
Product is missing warning declaration that it contains phenylalanine.
Published
March 29, 2023
Distribution
Products were distributed to the followi…

View recall →

FDA Recall Terminated Historical recordClass II

Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.

by Teva Pharmaceuticals USA Inc

Reason
Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7079-05

by AVEVA Drug Delivery Systems, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7077-05

by AVEVA Drug Delivery Systems, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427, NDC: 0574-2067-27

by Padagis US LLC

Reason
Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clobazam Tablets, 20 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-901-01

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-900-01

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP, 2 mg, CIV, packaged in: a)100-count bottle (NDC 51991-0707-01) and b) 500-count bottle (NDC 51991-0707-05), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC 51991-0706-05) and c) 1,000-count bottle (NDC 51991-0706-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP, 0.5mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0705-01), b) 500-count bottle (NDC 51991-0705-05) and c) 1,000-count bottle (NDC 51991-0705-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c) 1,000-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.

by Breckenridge Pharmaceutical, Inc

Reason
CGMP Deviations: Potential risk of Cross Contamination
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Navada Imports

Product
Soybean Lecithin Powder Packaged in 44 lb. (20 kg.) boxes
Reason
Undeclared peanut allergen
Published
March 22, 2023
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Navada Imports

Product
Sunflower Lecithin Powder Packaged in 44 lb. (20 kg.) boxes
Reason
Undeclared peanut allergen
Published
March 22, 2023
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.